Acute and chronic cisplatin nephropathy in rats

Area of Science:

• Nephrology
• Pharmacology
• Oncology

Background:

• Cisplatin (cis-dichlorodiammineplatinum-II) is a platinum-based chemotherapy agent with significant antitumor efficacy.
• Cisplatin administration is associated with dose-limiting nephrotoxicity, impacting renal function.
• Understanding the mechanisms of cisplatin nephropathy is crucial for managing its adverse effects.

Purpose of the Study:

• To investigate cisplatin-induced nephropathy in a rat model.
• To analyze the correlation between platinum accumulation in renal tissues and observed kidney damage.
• To evaluate the effects of both acute and chronic cisplatin treatment on kidney structure and function.

Main Methods:

• Rats were administered single intraperitoneal doses of cisplatin (6 mg/kg) or repeated doses (1 mg/kg, twice weekly for 11 weeks).
• Renal function and platinum concentration in kidney tissues were analyzed.
• Histopathological examination of kidney tissues was performed to assess tubular and glomerular damage.

Main Results:

• Acute cisplatin treatment induced focal necrosis in proximal and distal tubules, primarily in the corticomedullary region with high platinum concentration.
• Chronic cisplatin treatment resulted in thickened tubular basement membranes and fibrotic glomeruli, indicating irreversible renal damage.
• Platinum accumulation in the kidney correlated with the severity of tubular damage.

Conclusions:

• Cisplatin administration leads to significant nephropathy in rats, characterized by tubular necrosis and basement membrane thickening.
• Platinum toxicity is a likely major factor contributing to cisplatin-induced kidney damage.
• The findings highlight the potential for irreversible renal damage with chronic cisplatin exposure.